Kiniksa PharmaceuticalsKNSA
那斯達克 · USD
31.76
+1.50
(+4.96%)
盤中 08/02 02:46 (UTC+8)
08/02 02:46 (UTC+8)
Kiniksa PharmaceuticalsKNSA
31.76
+1.50
(+4.96%)
財務數據
損益表
- 0.62
- 0.48
- 0.71
- 0.67
- 0.83
- 0.80
- 1.09
- 1.12
- 1.23
- 1.38
- -37.58
- -21.88
- 47.84
- -6.19
- 24.38
- -4.24
- 36.03
- 3.30
- 9.20
- 12.44
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 137,785 | 122,536 | 112,214 | 108,631 | 79,858 | 83,395 | 67,046 | 71,473 | 48,345 | 61,884 |
營業成本 | 17,868 | 17,896 | 20,109 | 12,322 | 10,583 | 9,584 | 9,088 | 7,699 | 7,036 | 6,710 |
營業毛利 | 119,917 | 104,640 | 92,105 | 96,309 | 69,275 | 73,811 | 57,958 | 63,774 | 41,309 | 55,174 |
營業費用 | - | 123,939 | 101,763 | 96,426 | 85,817 | 73,730 | 68,885 | 66,928 | 52,505 | 49,127 |
研發費用 | 19,325 | 35,215 | 26,057 | 24,017 | 26,334 | 20,052 | 17,106 | 23,767 | 15,172 | 14,390 |
推銷及管理費用 | 87,320 | 88,724 | 75,706 | 72,409 | 59,483 | 53,678 | 51,779 | 43,161 | 37,333 | 34,737 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 13,272 | -19,299 | -9,658 | -117 | -16,542 | 81 | -10,927 | -3,154 | -11,196 | 6,047 |
其他收入及費用 | 2,293 | 2,320 | 2,457 | 2,421 | 2,266 | 2,369 | 2,428 | 1,915 | 1,832 | 794 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 15,565 | -16,979 | -7,201 | 2,304 | -14,276 | 2,450 | -8,499 | -1,239 | -9,364 | 6,841 |
所得稅 | 7,026 | -8,091 | 5,492 | 6,212 | 3,428 | -22,787 | 5,356 | -16,211 | 2,906 | 2,380 |
稅後純益 | 8,539 | -8,888 | -12,693 | -3,908 | -17,704 | 25,237 | -13,855 | 14,972 | -12,270 | 4,461 |
基本每股稅後盈餘(元) | 0.12 | -0.12 | -0.18 | -0.06 | -0.25 | 0.36 | -0.20 | 0.21 | -0.18 | 0.06 |
稀釋每股稅後盈餘(元) | 0.11 | -0.12 | -0.17 | -0.06 | -0.25 | 0.36 | -0.20 | 0.22 | -0.18 | 0.05 |
基本平均股數(千股) | 72647.00 | 72319.00 | 71726.00 | 71004.00 | 70633.00 | 70371.00 | 70186.00 | 69918.00 | 69751.00 | 69609.00 |
稀釋平均股數(千股) | 76145.00 | 72319.00 | 71726.00 | 71004.00 | 70633.00 | 72660.00 | 70186.00 | 71634.00 | 69751.00 | 71369.00 |
還原基本每股稅後盈餘(元) | 0.12 | -0.12 | -0.18 | -0.06 | -0.25 | 0.36 | -0.20 | 0.21 | -0.18 | 0.06 |
還原稀釋每股稅後盈餘(元) | 0.11 | -0.12 | -0.17 | -0.06 | -0.25 | 0.36 | -0.20 | 0.22 | -0.18 | 0.05 |
還原基本平均股數(千股) | 72,647 | 72,319 | 71,726 | 71,004 | 70,633 | 70,371 | 70,186 | 69,918 | 69,751 | 69,609 |
還原稀釋平均股數(千股) | 76,145 | 72,319 | 71,726 | 71,004 | 70,633 | 72,660 | 70,186 | 71,634 | 69,751 | 71,369 |
EBITDA(千元) | 16,165 | -15,760 | -7,289 | 2,546 | -13,513 | 2,694 | -6,455 | -1,789 | -9,829 | 7,240 |